0864-0289

0864-0289

S0864-02892019000300007

Cuba

00 09 2019

00 09 2019

35 3

1

2010 47 2 2

107-14

2

2015 2

99-111

3

2016 3

4

2016 87

2074-81

5

CD20 Expression and Effects on Outcome of Relapsed/Refractory Diffuse Large B Cell Lymphoma after Treatment with Rituximab 2018 19 2 2

331-5

6

2017

7

2012 4 4 4

488-96

8

2010 24

1101-7

9

2014 105 105

35-43

10

2013 5 1 1

22-33

11

1990 136 6 6

1215-22

12

2002 51 1 1

15-24

13

2014 7

530-44

14

2017 22

1-9

15

2009 113 16 16

3773-80